Clinical Trial
-
Biologics
Bone Biologics Reports Progress With NB1 Clinical Program
BURLINGTON, Mass., March 1, 2024–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress…
Read More » -
Biologics
BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting
— Blinded data from the ongoing Phase 2 clinical trial of BRTX-100 to be described in poster presentation — —…
Read More » -
Biologics
U.S. FDA Grants Lipogems® Second IDE Approval For A Clinical Trial On The Treatment For Knee OA
ATLANTA, Oct. 4, 2023 /PRNewswire/ — The U. S. Food and Drug Administration (FDA) has awarded Lipogems another Investigational Device Exemption (IDE) study…
Read More » -
Spine
Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System
Pioneering Safer and More Effective Solutions for Vertebral Fractures THE HAGUE, Netherlands, Oct. 3, 2023 /PRNewswire/ — Amber Implants, an innovative medical…
Read More » -
Biologics
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million
FREDERICK, Md., Sept. 26, 2023 /PRNewswire/ — Today, Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded…
Read More » -
Neuro
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States
Randomized controlled clinical trial expected to validate effectiveness of ReActiv8® Restorative NeurostimulationTM vs. optimal medical management DUBLIN, August 29, 2023–(BUSINESS WIRE)–Mainstay Medical…
Read More » -
Spine
Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial
LOUISVILLE, Colo., June 29, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc…
Read More » -
Spine
Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients
MINNEAPOLIS, June 15, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low…
Read More »